Form 4: Hinge Health CFO Sells Shares Under 10b5-1 Plan

Hinge Health's Chief Financial Officer, James Budge, sold 10,491 shares of Class A Common Stock for approximately $48.41 per share under a pre-arranged trading plan.

Summary

• James Budge, Chief Financial Officer of Hinge Health, Inc. (HNGE), reported a sale of Class A Common Stock.
• The transaction involved the disposition of 10,491 shares.
• The shares were sold on December 22, 2025, at a weighted average price of $48.4069 per share.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Budge on June 12, 2025.
• The individual sale prices ranged from a low of $47.81 to a high of $48.74 per share.
• Following this transaction, Mr. Budge directly beneficially owns 441,174 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan, which is generally considered neutral and not indicative of specific positive or negative company sentiment.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction is specific to Hinge Health and its Chief Financial Officer and does not directly relate to broader industry trends or competitive landscape analysis.

Stakeholder Impact

• Shareholders: Disclosure of insider trading provides transparency regarding executive stock ownership changes, which can inform investment decisions.

Key Dates

Recommendation

The filing details a pre-scheduled sale of shares by the CFO under a Rule 10b5-1 trading plan. Such transactions are generally routine and do not typically signal a change in the company's fundamental prospects or warrant an immediate shift in investment strategy. Investors should consider this a transparency disclosure rather than a strong buy or sell signal.

Keywords

Hinge Health, HNGE, Insider Trading, Form 4, James Budge, Stock Sale, CFO, 10b5-1 Plan